![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Preinitiation |
Unique ID issued by UMIN | UMIN000042893 |
Receipt No. | R000048962 |
Scientific Title | prognostic analysis of non-small cell lung cancer patients with pathological stage II-IIIB |
Date of disclosure of the study information | 2021/01/05 |
Last modified on | 2021/01/04 |
Basic information | ||
Public title | prognostic analysis of non-small cell lung cancer patients with pathological stage II-IIIB | |
Acronym | prognostic analysis of non-small cell lung cancer patients with pathological stage II-IIIB | |
Scientific Title | prognostic analysis of non-small cell lung cancer patients with pathological stage II-IIIB | |
Scientific Title:Acronym | prognostic analysis of non-small cell lung cancer patients with pathological stage II-IIIB | |
Region |
|
Condition | |||
Condition | Non-small cell lung cancer | ||
Classification by specialty |
|
||
Classification by malignancy | Malignancy | ||
Genomic information | NO |
Objectives | |
Narrative objectives1 | To determine the prognostic value of cisplatin unfit in postoperative lung cancer patients with stage II-III pathology requiring cisplatin-based adjuvant chemotherapy |
Basic objectives2 | Others |
Basic objectives -Others | Reasons why standard postoperative adjuvant chemotherapy could not be administered and alternative treatments |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Overall survival by postoperative adjuvant therapy |
Key secondary outcomes |
Base | |
Study type | Observational |
Study design | |
Basic design | |
Randomization | |
Randomization unit | |
Blinding | |
Control | |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | |
No. of arms | |
Purpose of intervention | |
Type of intervention | |
Interventions/Control_1 | |
Interventions/Control_2 | |
Interventions/Control_3 | |
Interventions/Control_4 | |
Interventions/Control_5 | |
Interventions/Control_6 | |
Interventions/Control_7 | |
Interventions/Control_8 | |
Interventions/Control_9 | |
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | patients who underwent surgery for non-small cell lung cancer between 2010 and 2020, patients with pathological stage II-IIIB requiring postoperative adjuvant chemotherapy as standard treatment will be included. | |||
Key exclusion criteria | Non-complete resection cases | |||
Target sample size | 500 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Nagoya University | ||||||
Division name | Graduate School of Medicine, Department of Thoracic Surgery | ||||||
Zip code | 4668550 | ||||||
Address | 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, JAPAN | ||||||
TEL | 0527442375 | ||||||
tyoshikawa@med.nagoya-u.ac.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Nagoya University | ||||||
Division name | Graduate School of Medicine, Department of Thoracic Surgery | ||||||
Zip code | 4668550 | ||||||
Address | 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, JAPAN | ||||||
TEL | 0527442375 | ||||||
Homepage URL | |||||||
shota197065@med.nagoya-u.ac.jp |
Sponsor | |
Institute | Nagoya University |
Institute | |
Department |
Funding Source | |
Organization | Nagoya University |
Organization | |
Division | |
Category of Funding Organization | Other |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Nagoya university hospital |
Address | 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan |
Tel | 0527442375 |
shota197065@med.nagoya-u.ac.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Preinitiation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information | retrospective observational study |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048962 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |